# Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases

> **NCT00026494** · PHASE1,PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 49 (actual)

## Conditions studied

- Metastatic Cancer

## Interventions

- **DRUG:** temozolomide
- **DRUG:** vinorelbine tartrate

## Key facts

- **NCT ID:** NCT00026494
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2016-01-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00026494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00026494, "Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00026494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*